Keyword: AstraZeneca

News

Amgen deal for Onyx possible Within Week

09.08.2013 - Onyx Pharmaceuticals is close to selling itself to larger rival Amgen as the cancer drug maker's high stock price has discouraged other companies from making a counteroffer so far...

News

AstraZeneca Warns Of Higher Costs As Drug Sales Slide

02.08.2013 - British drugmaker AstraZeneca warned on Thursday of higher costs in 2013 as it invests through a slump in sales caused by a wave of patent expiries on key medicines. The prediction...

News

Foreign Pharma Companies Could Be Probed In China

25.07.2013 - China's official news agency hinted that more foreign pharmaceutical firms could soon be implicated in a corruption scandal sweeping the industry, in the wake of bribery...

News

China Pharma Probe Widens, U.S. Citizen Detained

24.07.2013 - A U.S. citizen has been detained in China in connection with probes sparked by an unfolding corruption scandal in the drugs industry, as China widens the range of international...

News

Roche Takes Its Hunt For A New Chairman Further Afield

22.07.2013 - Swiss drugmaker Roche faces the prospect of hiring an outsider to replace its chairman of 16 years after its most suitable board members turned down the job. The 117-year old...

News

Vivus Gives First Manhattan Board Majority, Zook to be CEO

22.07.2013 - Vivus has agreed to give dissident shareholder First Manhattan a board majority, ending an acrimonious proxy fight and bringing in a new CEO to the drugmaker accused of bungling...

News

Vivus Says FMC Rejects Offer To Settle Proxy Fight

18.07.2013 - Obesity drug maker Vivus, embroiled in a bitter proxy war with its top shareholder First Manhattan, said on Wednesday that FMC had rejected an offer to give the sides equal...

News

AstraZeneca’s Simon Lowth to Quit for BG Group

16.07.2013 - Simon Lowth is to quit as chief financial officer at AstraZeneca and return to his energy roots in the same role at BG Group after being passed over for the top job at the...